<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2021.651221</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcription Factors of CAT1, EFG1, and BCR1 Are Effective in Persister Cells of <italic>Candida albicans</italic>-Associated HIV-Positive and Chemotherapy Patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Aboualigalehdari</surname> <given-names>Elham</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tahmasebi Birgani</surname> <given-names>Maryam</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Fatahinia</surname> <given-names>Mahnaz</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1190588/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hosseinzadeh</surname> <given-names>Mehran</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences</institution>, <addr-line>Ahvaz</addr-line>, <country>Iran</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences</institution>, <addr-line>Ahvaz</addr-line>, <country>Iran</country></aff>
<aff id="aff3"><sup>3</sup><institution>Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences</institution>, <addr-line>Ahvaz</addr-line>, <country>Iran</country></aff>
<aff id="aff4"><sup>4</sup><institution>Infectious and Tropical Diseases Research Center, Health Research Institute and Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences</institution>, <addr-line>Ahvaz</addr-line>, <country>Iran</country></aff>
<aff id="aff5"><sup>5</sup><institution>Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences</institution>, <addr-line>Ahvaz</addr-line>, <country>Iran</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Miguel Cacho Teixeira, University of Lisbon, Portugal</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Maryam Roudbary, Iran University of Medical Sciences, Iran; Jing Shao, Anhui University of Chinese Medicine, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Mahnaz Fatahinia, <email>fatahinia@yahoo.com</email></corresp>
<fn fn-type="other" id="fn002"><p><sup>&#x2020;</sup>ORCID: Elham Aboualigalehdari, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-2517-8847">orcid.org/0000-0002-2517-8847</ext-link>; Maryam Tahmasebi Birgani, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-9624-1903">orcid.org/0000-0002-9624-1903</ext-link>; Mahnaz Fatahinia, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-6898-1309">orcid.org/0000-0001-6898-1309</ext-link>; Mehran Hosseinzadeh, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-9761-3713">orcid.org/0000-0002-9761-3713</ext-link></p></fn>
<fn fn-type="other" id="fn004"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>08</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>651221</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>01</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>07</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2021 Aboualigalehdari, Tahmasebi Birgani, Fatahinia and Hosseinzadeh.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Aboualigalehdari, Tahmasebi Birgani, Fatahinia and Hosseinzadeh</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec><title>Background</title><p>Biofilm is an accumulation of cells, which are formed on mucosal surfaces of the host as well as on medical devices. The inherent resistance of <italic>Candida</italic> strains producing biofilms to antimicrobial agents is an important and key feature for biofilm growth, which can lead to treatment failure. This resistance is due to the regulatory increase of the output pumps, the presence of extracellular matrix, and the existence of persister cells. Persister cells are phenotypic variants that have MICs similar to antibiotic-sensitive populations and are able to tolerate high doses of antibiotics. The current study investigated the possible role of <italic>EFG1, BCR1</italic>, and <italic>CAT1</italic> in the establishment or maintenance of persister cells in <italic>Candida albicans</italic> strains that produce biofilms.</p></sec>
<sec><title>Methods</title><p>After identifying <italic>Candida</italic> isolates by molecular methods, <italic>C. albicans</italic> isolates were confirmed by sequencing. Isolation of persister cells and determination of their MIC were performed by microdilution method. Then, RNA extraction and cDNA synthesis were performed from 60 <italic>C. albicans</italic> isolates under promoting and inducing conditions. Afterward, the mean expression of <italic>BCR1, EFG1</italic>, and <italic>CAT1</italic> genes in both persister and non-persister groups was calculated using real-time qPCR. Phylogeny tree of persister and non-persister group isolates was drawn using ITS fragment.</p></sec>
<sec><title>Results</title><p>A total of 77 persister isolates were taken from the oral cavity of HIV patients as well as from patients undergoing chemotherapy. Biofilm intensity in persister isolates separated from HIV-infected patients was different from the non-persister group. The mean fold change of <italic>BCR1</italic> (10.73), <italic>CAT1</italic> (15.34), and <italic>EFG1</italic> (2.41) genes in persister isolates was significantly higher than these genes in isolates without persister.</p></sec>
<sec><title>Conclusion</title><p>It can be concluded that the most important factor in the production of persister cells is biofilm binding and production, not biofilm development or mature biofilm production, which was found in the expression of <italic>BCR1</italic> gene without change in the expression of <italic>EFG1</italic> gene in the persister group. Also, catalase plays an essential role in the production of persister in <italic>C. albicans</italic> biofilm producers with ROS detoxification.</p></sec>
</abstract>
<kwd-group>
<kwd>oral candidiasis</kwd>
<kwd>persister cells</kwd>
<kwd>biofilm</kwd>
<kwd>HIV patients</kwd>
<kwd>patients under chemotherapy</kwd>
<kwd><italic>BCR1</italic></kwd>
<kwd>EFG1</kwd>
<kwd><italic>CAT1</italic></kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="50"/>
<page-count count="13"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Oral candidiasis is known as the most common fungal infection. It is an opportunistic disease among humans, especially in patients undergoing chemotherapy, transplant recipients, and HIV patients. Aging, uncontrolled diabetes mellitus, broad-spectrum antibiotics, corticosteroid, and/or immunosuppressant drug use are predisposing factors for this disease. It acts also as a prognostic marker for systemic diseases such as diabetes mellitus and a common problem in immunocompromised patients such as HIV patients and those undergoing chemotherapy (<xref ref-type="bibr" rid="B2">Aboualigalehdari et al., 2013</xref>, <xref ref-type="bibr" rid="B1">2020</xref>; <xref ref-type="bibr" rid="B44">Taff et al., 2013</xref>; <xref ref-type="bibr" rid="B8">Cavalheiro and Teixeira, 2018</xref>; <xref ref-type="bibr" rid="B40">Putranti et al., 2018</xref>).</p>
<p>Studies have indicated that this disease occurs in about 80&#x2013;90% of HIV-positive patients and also in 7&#x2013;52% of patients undergoing chemotherapy. This infection is often detected in these patients in chronic and recurrent forms, especially in HIV-positive patients and leads to esophageal candidiasis and subsequent difficulty in digesting and swallowing (<xref ref-type="bibr" rid="B18">Jayachandran et al., 2016</xref>; <xref ref-type="bibr" rid="B36">Patil et al., 2018</xref>).</p>
<p><italic>Candida albicans</italic> is the most important causative agent of oral candidiasis as well as an opportunistic organism that exists as normal microflora on the skin and mucous membranes of the body. This organism causes superficial to systemic infections, and the mortality rate due to infections caused by this organism is reported to be 40%. The prevalence of <italic>C. albicans</italic> isolated orally from patients with leukemia undergoing chemotherapy is about 46.2%, and in AIDS patients, it has been reported to be 37.2&#x2013;95.2% (<xref ref-type="bibr" rid="B38">Piekarska et al., 2008</xref>; <xref ref-type="bibr" rid="B26">Li et al., 2015</xref>; <xref ref-type="bibr" rid="B36">Patil et al., 2018</xref>; <xref ref-type="bibr" rid="B49">Wuyts et al., 2018</xref>).</p>
<p>One of the important features in the pathogenicity of <italic>C. albicans</italic> is its ability to adhere and subsequently form a biofilm on biotic and abiotic surfaces such as mucosal surfaces as well as implanted medical devices. Biofilm formation is among the factors of resistance to antifungal drugs, which leads to treatment failure and disease recurrence. Several phenomena are implicated in biofilm resistance, including increased metabolic activity, production of extracellular biofilm matrix, cell density, upregulation of drug efflux pumps, persister cells, and stress responses (<xref ref-type="bibr" rid="B38">Piekarska et al., 2008</xref>; <xref ref-type="bibr" rid="B26">Li et al., 2015</xref>; <xref ref-type="bibr" rid="B49">Wuyts et al., 2018</xref>; <xref ref-type="bibr" rid="B17">Galdiero et al., 2020</xref>).</p>
<p>Another problem is the failure in the treatment of <italic>C. albicans</italic> infection leading to chronic infections. Recently, persister cells have attracted attention as a reason for drug tolerance in <italic>C. albicans</italic>. Persister cells are a special phenotypic type of biofilm population making up a small part of the biofilm population, which are capable of tolerating high doses of anti-fungal therapy. Thus, when a population of persister cells is exposed to a high dose of anti-fungal drugs, a small number of these cells survive, and interestingly, if they are re-cultured and re-exposed to a high dose of anti-fungal drugs, the fungi show a similar reaction. To our knowledge, many studies have indicated failure of anti-fungal drugs in <italic>C. albicans</italic>, which could be due to the presence of persister cells (<xref ref-type="bibr" rid="B9">Clinical and Laboratory Standards Institute [CLSI], 2008</xref>; <xref ref-type="bibr" rid="B41">Silva et al., 2012</xref>; <xref ref-type="bibr" rid="B28">Maheronnaghsh et al., 2020</xref>). For this purpose, this study was performed on fungal pathogens that had MIC associated with amphotericin B-sensitive populations and were exposed to very high doses of amphotericin B. The aim of this study was to better understand fungal persister cells for comparing biofilm intensity and expression of genes involved in biofilm production pathway (<italic>BCR1</italic> and <italic>EFG1</italic>) as well as oxidative stress response pathway (<italic>CAT1</italic>) in persister cells of <italic>C. albicans</italic> isolates taken from patients with HIV who underwent chemotherapy.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>In this study, 201 HIV patients and 200 cancer patients undergoing chemotherapy satisfying baseline criteria were studied with ethical code# IR.AJUMS.REC.1397.894.</p>
<sec id="S2.SS1">
<title>Inclusion Criteria</title>
<list list-type="simple">
<list-item>
<label>1.</label>
<p>Samples were isolated from patients who had one of the following symptoms: Patients who had inflamed lesions in the oral mucosa and on the tongue with red flakes, those who had a false white membrane in their oral cavity or creamy to white plaques, and patients whose sense of taste had changed or had dry mouth.</p>
</list-item>
<list-item>
<label>2.</label>
<p>After culturing the oral swab on CHROMagar<sup>TM</sup> <italic>Candida</italic> media, the number of colonies was counted and the grown samples were entered into the project with &#x2265; 10 colonies as patients colonized with <italic>Candida</italic> (<xref ref-type="bibr" rid="B15">Erk&#x00F6;se and Erturan, 2007</xref>).</p>
</list-item>
<list-item>
<label>3.</label>
<p>Confirmation of <italic>C. albicans</italic> samples was molecular and macroscopic.</p>
</list-item>
<list-item>
<label>4.</label>
<p>Insertion of persister <italic>C. albicans</italic> isolates with MIC related to amphotericin B-sensitive population (MIC &#x003C; 2 &#x03BC;g/ml) as well as non-persister <italic>C. albicans</italic> (<xref ref-type="bibr" rid="B9">Clinical and Laboratory Standards Institute [CLSI], 2008</xref>; <xref ref-type="bibr" rid="B28">Maheronnaghsh et al., 2020</xref>).</p>
</list-item>
</list>
</sec>
<sec id="S2.SS2">
<title>Sample Collection and Phenotypic Identification</title>
<p>The samples taken from the patients were transferred to the Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Then, the samples were cultured on CHROMagar<sup>TM</sup> <italic>Candida</italic> media (CHROMagar<sup>TM</sup>, Pioneer, Paris, France) and incubated at 35&#x00B0;C for 48&#x2013;72 h. In the next step, the grown clinical isolates were compared and identified in terms of colony color based on the desired culture medium brochure and standard samples. Then, the culture medium was examined for colony diversity and the colonies were counted based on colony-forming unit/swab. After that, the isolates were purified on Sabouraud Dextrose Agar + Chloramphenicol (SC) (Liofilchem, Italy). The medium and the isolates were transferred to microtubes containing sterile distilled water for long-term storage (6 months) at two temperatures: 30&#x00B0;C and room temperature.</p>
</sec>
<sec id="S2.SS3">
<title>DNA Extraction</title>
<p>The genomic DNA was directly extracted by boiling method (<xref ref-type="bibr" rid="B50">Yamada et al., 2002</xref>; <xref ref-type="bibr" rid="B41">Silva et al., 2012</xref>).</p>
</sec>
<sec id="S2.SS4">
<title>PCR-RFLP, Sequencing, and Duplex PCR</title>
<p>To confirm the isolates as <italic>C. albicans</italic>, PCR-RFLP, sequencing, and duplex PCR were performed. The primers for PCR-RFLP are listed in <xref ref-type="table" rid="T1">Table 1</xref>, and the enzyme for PCR-RFLP was <italic>Msp</italic>I. Sequencing was done after PCR of V9g and LS266 area as shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Primers for PCR-RFLP, sequencing, and duplex PCR.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"><bold>Genes</bold></td>
<td valign="top" align="center"><bold>5&#x2032; to 3&#x2032;</bold></td>
<td valign="top" align="center"><bold>Method</bold></td>
<td valign="top" align="center"><bold>References</bold></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">ITS1</td>
<td valign="top" align="center">Forward: TCC GTA GGT GAA CCT TGC GG</td>
<td valign="top" align="center">PCR-RFLP</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B3">Abraham et al., 2020</xref></td>
</tr>
<tr>
<td valign="top" align="left">ITS4</td>
<td valign="top" align="center">Reverse: TCC TCC GCT TAT TGA TAT GC</td>
<td valign="top" align="center">PCR-RFLP</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B3">Abraham et al., 2020</xref></td>
</tr>
<tr>
<td valign="top" align="left">CAL</td>
<td valign="top" align="center">Forward: TGGTAAGGCGGGATCGCTT</td>
<td valign="top" align="center">duplex PCR</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B14">El-Baz et al., 2021</xref></td>
</tr>
<tr>
<td/>
<td valign="top" align="center">Reverse: GGTCAAAGTTTGAAGATATAC</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">CDU</td>
<td valign="top" align="center">Forward: AACTTGTCACGAGATTATTTTT</td>
<td valign="top" align="center">duplex PCR</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B14">El-Baz et al., 2021</xref></td>
</tr>
<tr>
<td/>
<td valign="top" align="center">Reverse: AAAGTTTGAAGAATAAAATGGC</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">V9g</td>
<td valign="top" align="center">Forward: TTACGTCCCTGCCCTT TGTA</td>
<td valign="top" align="center">PCR</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B27">Li et al., 2018</xref></td>
</tr>
<tr>
<td valign="top" align="left">LS266</td>
<td valign="top" align="center">Reverse: GCATT CCCAAACAACTCGACTC</td>
<td valign="top" align="center">PCR</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B27">Li et al., 2018</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="S2.SS5">
<title>Biofilm Formation Assay</title>
<p>Biofilm production was performed on RPMI 1640 medium. All isolates were cultured in Sabouraud Dextrose Broth and incubated in a shaker incubator at 30&#x00B0;C for 24 h. After 24 h, the grown colonies were washed twice with sterile phosphate buffer solution (1&#x00D7; PBS) (pH 7.4) (Sigma-Aldrich) and centrifuged at 6063 rpm for 3 min at 4&#x00B0;C (SIGMA 1-15PK). Then, a yeast suspension was prepared from colonies with a concentration of 10<sup>6</sup> cfu/ml in RPMI 1640 medium. Subsequently, in each well of flat bottom 96 microplates, 200 &#x03BC;l of suspension was poured in the wells. Culture medium was considered as the negative control and culture medium plus yeast suspension was the positive control. The microplates were placed at 37&#x00B0;C for 48 h. After this period, the culture medium in each well was emptied, and the wells were washed three times with sterile PBS. The microplates were then inverted at room temperature for an hour to dry. One hundred microliters of 0.1% crystal violet solution was added to each well and the microplate was placed at 37&#x00B0;C for 15 min without moving. Then, it was removed from the wells and washed again with sterile PBS, and the microplates were dried at room temperature. In the next step, 100 &#x03BC;l of 96% ethanol was poured into each well and the microplate was gently shaken in a circle by hand to extract the crystal violet color bound to the yeasts forming the biofilm faster. Then, the optical density (OD) of this solution was measured at 595 nm with a microplate reader (BioTek, Elx808). Finally, the biofilms were classified using the following formula (<xref ref-type="bibr" rid="B3">Abraham et al., 2020</xref>; <xref ref-type="bibr" rid="B14">El-Baz et al., 2021</xref>):</p>
<p>No biofilm: Absorbance &#x2264; Absorbance Control</p>
<p>Weak biofilm: Ac &#x003C; A &#x2264; (2 &#x00D7; Ac)</p>
<p>Moderate biofilm: (2 &#x00D7; Ac) &#x003C; A &#x2264; (4 &#x00D7; Ac)</p>
<p>Strong biofilm: (4 &#x00D7; Ac) &#x003C; A</p>
<p>The isolates were grouped based on OD value. The isolates with low biofilm formation (LBF) were classified as first quarter (Q1); those with greater OD values were defined in the third quarter, which had high biofilm formation (HBF) (Q3), and the isolates with OD values between the first and third quarters were classified as second quarter and possessed intermediate biofilm formation (IBF) (Q2) (<xref ref-type="bibr" rid="B27">Li et al., 2018</xref>).</p>
</sec>
<sec id="S2.SS6">
<title>Persister Cell Assay</title>
<p>All the isolates were cultured on Sabouraud Dextrose Broth and incubated in a shaker incubator at 30&#x00B0;C for 24 h. After this time, the grown colonies were washed twice with sterile PBS and centrifuged at 6063 rpm for 3 min at 4&#x00B0;C. A yeast suspension with a concentration of 10<sup>6</sup> cfu/ml was subsequently prepared from colonies in RPMI 1640 medium. One hundred microliters of the prepared yeast suspension was added to each well of 96-well flat bottom microplate, which was placed at 37&#x00B0;C for 4 h. After this period, the culture medium in each well was discarded and washed with PBS, 100 &#x03BC;l of RPMI1640 culture medium was added to the wells and incubated for 24 h at 37&#x00B0;C. The culture medium in each well was emptied, and 200 &#x03BC;l of amphotericin B (Sigma Aldrich-USA) diluted with RPMI1640 with a concentration of 100 &#x03BC;g/ml (<xref ref-type="bibr" rid="B31">Moazeni et al., 2014</xref>; <xref ref-type="bibr" rid="B12">De Brucker et al., 2016</xref>; <xref ref-type="bibr" rid="B5">Alonso et al., 2018</xref>) was added to the wells and placed at 37&#x00B0;C for 48 h, after which the contents of each well were discarded and washed once with 100 &#x03BC;l of PBS. After washing, 100 &#x03BC;l of PBS was added to each well and homogenized using a sterile pipette. Twenty microliters from each well was serially diluted in 1:10 ratio in 10 dilutions of PBS. After dilution, 50 &#x03BC;l of each well was harvested and cultured on yeast peptone dextrose agar or YPD medium (Liofilchem, Italy). The plates were kept in an incubator at 48&#x00B0;C for 48&#x2013;72 h. The plates were examined for colony count after 48 h and the samples were reported in three categories: high persister, low persister, and non-persister (<xref ref-type="bibr" rid="B21">LaFleur et al., 2006</xref>, <xref ref-type="bibr" rid="B22">2010</xref>). Finally, samples containing persister cells were examined for MIC determination of amphotericin B according to CLSI M27-S4 guidelines, and if they were sensitive to the population with MIC &#x003C; 2 &#x03BC;g/ml, the samples were confirmed as persister isolates (<xref ref-type="bibr" rid="B9">Clinical and Laboratory Standards Institute [CLSI], 2008</xref>; <xref ref-type="bibr" rid="B28">Maheronnaghsh et al., 2020</xref>).</p>
</sec>
<sec id="S2.SS7">
<title>Evaluation of the Genes Responsible for Biofilm Formation and Oxidative Stress Among Isolates Producing Persister Cells</title>
<p>To determine the maximum and minimum survival rates, the isolates were ranked from highest to lowest based on their survival rates against amphotericin and then the first 15 isolates with the highest survival rates were specified as the persister group and the last 15 isolates not showing survival were chosen as those without persister or non-persister group. There were a total of 30 isolates in these two groups. Evaluation of <italic>BCR1, EFG1</italic>, and <italic>CAT1</italic> gene expression was performed in 30 <italic>C. albicans</italic> isolates by the real-time qPCR method. Real-time qPCR was done on isolates that were under inducing and promoting conditions.</p>
<p>Inducing conditions were applied for isolates in the state of biofilm production while promoting conditions were meant for isolates in the normal condition, and RNA was extracted from these isolates. In other words, the promoting conditions are the conditions before the formation of biofilm, and the inducing conditions are those after the formation of biofilm. Promoting conditions mean the alteration in expression of genes that cause biofilms and inducing conditions are changing the expression of genes causing biofilm formation to give specific properties to cells.</p>
<p>For this purpose, RNA was first extracted (RNX-Plus) and then the purity and integrity of extracted RNA were investigated under both conditions by nanodrop and loading of RNA on agarose gel, after which cDNA was synthesized from RNA (BioFact, South Korea). Finally, real-time qPCR was performed using Real-Time PCR Roche lightcycler<sup>&#x00AE;</sup> 96, BioFACT<sup>TM</sup> 2X Real-Time PCR Master Mix, and the primers listed in <xref ref-type="table" rid="T2">Table 2</xref>. Real-time qPCR was carried out with the following reaction conditions: 40 cycles of denaturation: 15 s at 95&#x00B0;C; annealing: 60 s at 60&#x00B0;C; and extension: 60 s at 72&#x00B0;C.</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>qPCR primers.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"><bold>Genes</bold></td>
<td valign="top" align="center"><bold>Primer sequence (5&#x2032;&#x2192;3&#x2032;)</bold></td>
<td valign="top" align="center"><bold>Size (bp)</bold></td>
<td valign="top" align="center"><bold>Gene Bank</bold></td>
<td valign="top" align="center"><bold>GC%</bold></td>
<td valign="top" align="center"><bold>TM</bold></td>
<td valign="top" align="center"><bold>References</bold></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><italic>BCR1</italic></td>
<td valign="top" align="center">Forward CTTCAGCAGCTTCATTAACACCTA</td>
<td valign="top" align="center">101</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NC_032096.1">NC_032096.1</ext-link></td>
<td valign="top" align="center">41.7</td>
<td valign="top" align="center">68</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B22">LaFleur et al., 2010</xref></td>
</tr>
<tr>
<td/>
<td valign="top" align="center">Revers TCTTGGATCAGGTGTACTTTTCAA</td>
<td/>
<td/>
<td valign="top" align="center">37.5</td>
<td valign="top" align="center">66</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><italic>EFG1</italic></td>
<td valign="top" align="center">Forward TGCCAATAATGTGTCGGTTG</td>
<td valign="top" align="center">100</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="XM_709144.2">XM_709144.2</ext-link></td>
<td valign="top" align="center">45</td>
<td valign="top" align="center">58</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B34">Nikoomanesh et al., 2016</xref></td>
</tr>
<tr>
<td/>
<td valign="top" align="center">Revers CCCATCTCTTCTACCACGTGTC</td>
<td/>
<td/>
<td valign="top" align="center">54</td>
<td valign="top" align="center">68</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><italic>CAT1</italic></td>
<td valign="top" align="center">Forward GACTGCTTACATTCAAAC</td>
<td valign="top" align="center">117</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NC_032089.1">NC_032089.1</ext-link></td>
<td valign="top" align="center">38.9</td>
<td valign="top" align="center">55.1</td>
<td valign="top" align="center"><xref ref-type="bibr" rid="B31">Moazeni et al., 2014</xref></td>
</tr>
<tr>
<td/>
<td valign="top" align="center">Revers AACTTACCAAATCTTCTCA</td>
<td/>
<td/>
<td valign="top" align="center">31.9</td>
<td valign="top" align="center">55.1</td>
<td/>
</tr>
<tr>
<td valign="top" align="left"><italic>ACT1</italic></td>
<td valign="top" align="center">Forward ACTGCTTTGGCTCCATCTTCT</td>
<td valign="top" align="center">166</td>
<td valign="top" align="center"><ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="XM_019475182.1">XM_019475182.1</ext-link></td>
<td valign="top" align="center">48</td>
<td valign="top" align="center">65</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">Revers TGTGGTGAACAATGGATGGAC</td>
<td/>
<td/>
<td valign="top" align="center">48</td>
<td valign="top" align="center">62</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>Primer efficiency was determined for all the gene expression assays using a standard curve and LinRegPCR software. The absence of dimer primers and contamination was controlled by observing the melting curves and loading products on the agarose gel. The absence of DNA was also checked with no RT control (no reverse transcriptase control). The expression level of <italic>EFG1, BCR1</italic>, and <italic>CAT1</italic> target genes in the isolates relative to that of the reference <italic>ACT1</italic> gene was first calculated manually by Excel and then confirmed by REST2009 software to ensure the accuracy of results. Finally, statistical analysis and plotting with SPSS 22 and GraphPad prism were done.</p>
</sec>
<sec id="S2.SS8">
<title>Sequencing and Comparison of Persister and Non-persister Cells Using ITS Fragment</title>
<p>After sequencing of both groups, a software was used to draw the phylogenetic tree<sup><xref ref-type="fn" rid="footnote1">1</xref></sup>, and the phylogenetic tree of <italic>C. albicans</italic> isolates was used using Maximum Likelihood and Boot Strap 100 to ensure the validity and reproducibility of the drawn trees. The table of genetic distances was drawn using MEGA 7 program of Pairwise Distances model. Then, cluster and clade were determined in the phylogenetic tree.</p>
</sec>
<sec id="S2.SS9">
<title>Statistical Analysis</title>
<p>In this study, <italic>t</italic>-test and one-way ANOVA, Fisher&#x2019;s exact test, and Mann&#x2013;Whitney test with a significance level of &#x003C;0.05 were used. The normality of data was checked using Shapiro&#x2013;Wilk test. All tests were analyzed by SPSS software version 22.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<p>A total of 104 <italic>C. albicans</italic> were isolated. Forty-three isolates were taken from patients undergoing chemotherapy and 61 <italic>C. albicans</italic> isolates were identified in HIV patients. All the isolates were confirmed by phenotypic and molecular methods to be <italic>C. albicans</italic>. Afterward, 104 <italic>C. albicans</italic> isolates, including isolates collected from HIV-infected patients and those undergoing chemotherapy, were examined to determine the severity of biofilm formation.</p>
<sec id="S3.SS1">
<title><italic>C. albicans</italic> Is a Strong Biofilm Producer</title>
<p>Our analysis demonstrated that two isolates had a weak biofilm formation while 102 <italic>C. albicans</italic> isolates showed strong biofilm production. Another classification was also performed based on optical observation of the isolates that were grouped to three quarters as shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Determination of biofilm production level based on OD quarter; 25% of the isolates had 1.79 &#x2264; OD (LBF), 50% had 2.5 &#x2264; OD (IBF), and 75% of the isolates had 4.9 &#x2264; OD (HBF). LBF, low biofilm formation; IBF, intermediate biofilm formation; HBF, high biofilm formation.</p></caption>
<graphic xlink:href="fmicb-12-651221-g001.tif"/>
</fig>
</sec>
<sec id="S3.SS2">
<title>The Prevalence of <italic>C. albicans</italic> Persister Cell Producers Is High Among <italic>C. albicans</italic> Population</title>
<p>In this study, 104 <italic>C. albicans</italic> isolates were tested to separate persister cells from biofilm-forming isolates. This stage of persister cell isolation was done in triplicate and the results of each sample were reported as average. Out of 104 isolates under study that were exposed to 100 &#x03BC;g/ml amphotericin B, 83 had a survival rate in the range of 0.0003&#x2013;9% and 21 had no survival ability in the face of the drug. Those isolates that were able to survive in the presence of amphotericin B were examined for MIC. To determine the sensitivity of the population, MICs of the isolates were read by microdilution method in the presence of amphotericin B in the range of 0.3&#x2013;2 &#x03BC;g/ml. According to available guidelines, namely, CLSI M27-S4, out of 83 isolates, 77 with MIC &#x003C; 2 &#x03BC;g/ml were sensitive and six isolates with MIC &#x2265; 2 &#x03BC;g/ml were classified as the resistant population and were excluded from the study. Therefore, 77 <italic>C. albicans</italic> were considered as persister cell isolates (<xref ref-type="table" rid="T3">Table 3</xref> and <xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<table-wrap position="float" id="T3">
<label>TABLE 3</label>
<caption><p>The persister situation in infected patients with <italic>C. albicans</italic>.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left" colspan="4"><bold>Persister cell (survival rate)</bold></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>Patients</bold></td>
<td valign="top" align="center"><bold>High-persister</bold></td>
<td valign="top" align="center"><bold>Low-persister</bold></td>
<td valign="top" align="center"><bold>Non-persister</bold></td>
</tr>
<tr>
<td colspan="4"><hr/></td>
</tr>
<tr>
<td valign="top" align="left">Cancer patients (39)</td>
<td valign="top" align="center">1 (8%)</td>
<td valign="top" align="center">26 (0.0003&#x2013;0.75%)</td>
<td valign="top" align="center">12</td>
</tr>
<tr>
<td valign="top" align="left">HIV patients (59)</td>
<td valign="top" align="center">1 (9%)</td>
<td valign="top" align="center">49 (0.0003&#x2013;0.75%)</td>
<td valign="top" align="center">9</td>
</tr>
<tr>
<td valign="top" align="left">Total patients (98)</td>
<td valign="top" align="center">2 (8&#x2013;9%)</td>
<td valign="top" align="center">75 (0.0003&#x2013;0.75%)</td>
<td valign="top" align="center">21</td>
</tr>
<tr>
<td valign="top" align="left">Total patients (100%)</td>
<td valign="top" align="center">2.04%</td>
<td valign="top" align="center">76.5%</td>
<td valign="top" align="center">21.42%</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Mean survival rate or persister cell of <italic>Candida albicans</italic> isolates based on logarithmic data.</p></caption>
<graphic xlink:href="fmicb-12-651221-g002.tif"/>
</fig>
<p>According to a study by <xref ref-type="bibr" rid="B22">LaFleur et al. (2010)</xref>, the isolates with a survival rate of &#x003E;6% were defined as high persister, and those showing survival &#x003C;6% were classified as low-persister cells. Besides, the isolates that had no survival were defined as non-persistent (<xref ref-type="bibr" rid="B10">Cohen et al., 2013</xref>).</p>
<p>Out of 77 <italic>C. albicans</italic> persister cells, two isolates with 9% and 8% survival were classified in the high-persister cell group, 75 isolates with the ability to survive in 0.75&#x2013;0.0003% were classified in the low-persister group, and the 21 remaining isolates were classified in the non-persister group. Two high-persister isolates were taken from patients as follows: one was related to a patient undergoing chemotherapy who was hospitalized for approximately 2 months and did not have clear oral candidiasis symptoms. The only symptoms were dry mouth and redness of the tongue. Another isolate was taken from an HIV-infected patient recently discharged from the infectious ward of Razi Hospital who had been hospitalized for approximately 45 days. He had redness, inflammation, dry mouth, change in taste, and burning sensation, and of course, was in the end stage of the disease or so-called AIDS. According to the case file in Razi Hospital, only fluconazole was used for the patient whose disease was chronic and recurrent (<xref ref-type="table" rid="T4">Table 4</xref>).</p>
<table-wrap position="float" id="T4">
<label>TABLE 4</label>
<caption><p>Information from two patients with high persister cells isolated from <italic>Candida albicans</italic>.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"><bold>Age</bold></td>
<td valign="top" align="center"><bold>Candida-load</bold></td>
<td valign="top" align="center"><bold>Viral-load</bold></td>
<td valign="top" align="center"><bold>CD4-count</bold></td>
<td valign="top" align="center"><bold>Type of cancer</bold></td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="center"><bold>cells/mm<sup>3</sup></bold></td>
<td/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">High persister (patient under chemotherapy)</td>
<td valign="top" align="center">75</td>
<td valign="top" align="center">20</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">Lung</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">Colonization</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">High persister (HIV patient)</td>
<td valign="top" align="center">45</td>
<td valign="top" align="center">10<sup>5</sup></td>
<td valign="top" align="center">3,069,499</td>
<td valign="top" align="center">70</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">Infection</td>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>The mean production of low persister based on survival rate in HIV-infected patients with the ability of 0.04 &#x00B1; 0.14% (survival rate &#x00B1; standard deviation) was almost 5.5 times higher than patients undergoing chemotherapy with the ability of 0.008 &#x00B1; 0.13%. The mean of low persister production in all patients was 0.01 &#x00B1; 0.0013%. Since the survival rate and the number of high persisters in patients under study were almost the same, the same mean value was observed for both groups of patients (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Log mean persister production in patients undergoing chemotherapy and HIV patients.</p></caption>
<graphic xlink:href="fmicb-12-651221-g003.tif"/>
</fig>
</sec>
<sec id="S3.SS3">
<title>Comparison of Biofilm Intensity With Persister Cells in <italic>C. albicans</italic></title>
<p>In this part of the research, we first deal with the relationship between different variables related to HIV patients with those related to patients undergoing chemotherapy with the production of persister cells, and then this variable is examined in all patients.</p>
</sec>
<sec id="S3.SS4">
<title>HIV Patients</title>
<p>In this study, because there was only one isolate from HIV patients with a survival rate of 9%, statistical analysis was performed only in low and non-persister categories. Statistical results showed no significant correlation between qualitative variables of gender, tuberculosis, pneumocystosis, hepatitis B, hepatitis C, receiving antiviral drugs, tuberculosis prophylaxis drugs, HIV transmission from mother to child or through occupational exposure, blood transfusion, CD4 count, homosexuality, common syringe use for injection, and history of drug injection in non- and low-persister cells (<xref ref-type="supplementary-material" rid="TS1">Supplementary Table 1</xref>).</p>
<p>Data related to the age of subjects were normal, and no significant difference was observed between the two groups (low- and non-persister cells). There was no significant difference between viral and <italic>Candida</italic> loads between the two groups of non- and low-persister cells. However, the results of statistical tests showed that the biofilm variable is significantly different in the two groups of non- and low-persister cells (<xref ref-type="supplementary-material" rid="TS2">Supplementary Table 2</xref>) (<italic>p</italic> = 0.021).</p>
</sec>
<sec id="S3.SS5">
<title>Patients Undergoing Chemotherapy</title>
<p>Considering that there was only one isolate in this group with a survival rate of 8% among the high-persister group, the statistical analysis was performed for two groups: low- and non-persister cells. Accordingly, the calculations showed that there was no significant relationship between gender and persister values in the non- and low persister cell groups.</p>
<p>Data related to the age of subjects were normal and no significant difference was observed between the two groups. Statistical results also showed no significant difference in <italic>Candida</italic> load and biofilm variables between the two groups (<xref ref-type="supplementary-material" rid="TS3">Supplementary Table 3</xref>).</p>
<p>Statistical analysis was performed using <italic>t</italic>-test in the two groups of non- and low-persister cells, but no significant difference was observed between the two groups (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>The mean severity of biofilm in the groups of persister and non-persister cells in patients with HIV and those undergoing chemotherapy. A significant relationship between persister cells and biofilm intensity is seen only in HIV-infected patients (<italic>t</italic>-test, <italic>p</italic>-value &#x003C; 0.05).</p></caption>
<graphic xlink:href="fmicb-12-651221-g004.tif"/>
</fig>
</sec>
<sec id="S3.SS6">
<title>The Higher Expression of <italic>EFG1, BCR1</italic>, and <italic>CAT1</italic> in <italic>C. albicans</italic> Isolates Producing Persister Cells</title>
<p>Real-time qPCR was performed in promoting and inducing conditions. The purity of RNA on the A260/A280 and A260/A230 ratios was 1.8&#x2013;2.0 and 1.9&#x2013;2.0, respectively. Then, for the synthesis of cDNA, 500 ng of RNA entered the reaction.</p>
</sec>
<sec id="S3.SS7">
<title>Promoting Condition</title>
<p>After normalizing the data with reference or control gene (<italic>ACT1</italic>), our findings showed an increase in the expression of <italic>EFG1, BCR1</italic>, and <italic>CAT1</italic> genes in persister isolates, among which the highest expression was related to <italic>CAT1</italic> gene, followed by <italic>EFG1</italic> and <italic>BCR1</italic>, respectively.</p>
<p>The mean expression of <italic>EFG1, BCR1</italic>, and <italic>CAT1</italic> genes was statistically evaluated using logarithmic data between the two groups of persister and non-persister isolates using <italic>t</italic>-test. Among the genes, only the expression of the <italic>CAT1</italic> gene was significant between persister and non-persister isolates (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 1</xref>).</p>
</sec>
<sec id="S3.SS8">
<title>Inducing Condition</title>
<p>In inducing conditions, the expression of <italic>EFG1, BCR1</italic>, and <italic>CAT1</italic> genes was evident in all isolates of both persister and non-persister groups. After normalizing the data with reference or control gene of <italic>ACT1</italic>, our results showed an increase in the expression of <italic>EFG1, BCR1</italic>, and <italic>CAT1</italic> genes in persister isolates under inducing conditions, among which the highest expression was related to <italic>CAT1</italic> gene, then <italic>BCR1</italic> and <italic>EFG1</italic>, respectively. The mean expression of <italic>EFG1, BCR1</italic>, and <italic>CAT1</italic> genes was statistically evaluated through logarithmic data between the two groups of persister and non-persister using <italic>t</italic>-test. The increasing expression of <italic>BCR1</italic> and <italic>CAT1</italic> was significant between the persister and non-persister groups (<italic>p</italic> &#x003C; 0.05) (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 1</xref>).</p>
<p>The mean increase in gene expression under promoting and inducing conditions is described as fold change (i.e., 2<sup>&#x2013;&#x0394;&#x0394;CT</sup>). The highest amount of fold change in both promoting and inducing conditions was related to the <italic>CAT1</italic> gene with 15.34 and 5.54, respectively. The lowest fold change in promoting and inducing conditions was related to <italic>EFG1</italic> gene and its amount was 2.18 and 1.14, respectively (<xref ref-type="table" rid="T5">Table 5</xref> and <xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<table-wrap position="float" id="T5">
<label>TABLE 5</label>
<caption><p>Comparison of mean fold change (2<sup>&#x2013;&#x0394;&#x0394;CT</sup>) in <italic>EFG1</italic>, <italic>BCR</italic>, and <italic>CAT1</italic> genes under two conditions: promoting and inducing.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"></td>
<td valign="top" align="center"><bold><italic>BCR-P</italic></bold></td>
<td valign="top" align="center"><bold><italic>BCR-I</italic></bold></td>
<td valign="top" align="center"><bold><italic>EFG-P</italic></bold></td>
<td valign="top" align="center"><bold><italic>EFG-I</italic></bold></td>
<td valign="top" align="center"><bold><italic>CAT-P</italic></bold></td>
<td valign="top" align="center"><bold><italic>CAT-I</italic></bold></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Persister</td>
<td valign="top" align="center">3.58 &#x00B1; 0.25</td>
<td valign="top" align="center">10.73 &#x00B1; 0.4</td>
<td valign="top" align="center">1.14 &#x00B1; 0.15</td>
<td valign="top" align="center">2.41 &#x00B1; 0.49</td>
<td valign="top" align="center">5.54 &#x00B1; 0.53</td>
<td valign="top" align="center">15.34 &#x00B1; 0.69</td>
</tr>
<tr>
<td valign="top" align="left">Normal</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
</tr>
<tr>
<td valign="top" align="left"><italic>P</italic>-value (&#x003C;0.05)</td>
<td valign="top" align="center">0.08</td>
<td valign="top" align="center">0.008&#x002A;</td>
<td valign="top" align="center">0.1</td>
<td valign="top" align="center">0.1</td>
<td valign="top" align="center">0.03&#x002A;</td>
<td valign="top" align="center">0.016&#x002A;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>SD, standard deviation; P, promoting; I, inducing (<italic>t</italic>-test,&#x002A;<italic>P</italic>-value &#x003C; 0.05).</italic></attrib>
</table-wrap-foot>
</table-wrap>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>Fold change of 2<sup>&#x2013;&#x0394;&#x0394;CT</sup> related to <italic>CAT1, BCR1</italic>, and <italic>EFG1</italic> genes in persister and non-persister isolates in inducing and promoting conditions (<italic>t</italic>-test, &#x002A;<italic>p</italic>-value &#x003C;0.05, &#x002A;&#x002A;<italic>p</italic>-value &#x003C;0.01).</p></caption>
<graphic xlink:href="fmicb-12-651221-g005.tif"/>
</fig>
</sec>
<sec id="S3.SS9">
<title>Phylogenetic Tree in Persister and Non-persister Groups by ITS Component</title>
<p>The DNA sequencing analysis of 20 isolates confirmed the presence of <italic>C. albicans</italic> and was recorded on DNA Data Bank of Japan (Accession No. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="LC612887">LC612887</ext-link>-<ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="612906">612906</ext-link>). After blasting, the similarity of sequences was reported to be 94&#x2013;99.88%. The bootstrapping value was repeated 100 times to draw the phylogenetic tree to ensure the accuracy of drawing the phylogenetic tree. In our study, bootstrapping equal to 100 was reported, indicating that the phylogenetic tree of the desired nucleotides had a high degree of reliability. The similarity and intra-species difference of the sequences is calculated through pairwise distance. The average pairwise distance in sequences with a distance scale of 0.01 was 0.029. In these isolates, the biggest difference was related to 1A&#x2013;low persister and 5A-normal isolates, which was equal to 8%. Then, the difference was related to 1A&#x2013;low persister with normal 3A, 7A, and 8A isolates with a value of 7.8%. The isolate 6A&#x2013;high persister, 5A-normal, and then 7A, 8A, and 3A had the highest difference (approximately 7%). The 6A&#x2013;high-persister isolate had a genetic distance of 5.7% with the 7C&#x2013;high-persister isolate.</p>
<p>Based on the mean pairwise distance of 0.029, the sequences were divided into four clusters that were more genetically similar. The largest cluster belongs to cluster IV, which contains persister cell isolates and non-persister ones. Both high-persistent isolates were genetically separated by 5.7% in two separate clusters, and their offspring were completely different. 7c&#x2013;high persister had no significant difference from the normal population, including 8A, 7A, 5A, 3A, 4A, 2A, and 6C by about 1&#x2013;2% and was probably derived from the normal population. Most low-persister isolates differ by about 1% from the population of normal isolates, indicating that the nucleotide changes were negligible (<xref ref-type="fig" rid="F6">Figure 6</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p>Based on the mean pairwise distance of 0.029, the phylogenetic tree of the isolates shows four clusters.</p></caption>
<graphic xlink:href="fmicb-12-651221-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="S4">
<title>Discussion</title>
<p>Over the past 30 years, advances in medical science have caused a significant increase in life-threatening candidiasis, which has a high prevalence and mortality associated with invasive candidiasis infections, despite progress in fungal drugs (<xref ref-type="bibr" rid="B11">Costa-de-Oliveira and Rodrigues, 2020</xref>). Today, despite drug susceptibility tests and appropriate treatments, comprehensive medicine has faced the phenomena of treatment failure and recurrence of the disease in patients. It is a concern in medical science to treat a patient with appropriate antifungal medication without failure in antifungal therapy. In fungi and bacteria, this likelihood increases such that populations of drug tolerance and persister cells may be overlooked, leading to treatment failure (<xref ref-type="bibr" rid="B25">Lewis, 2005</xref>).</p>
<p>The present study suggests that persister cells are present in <italic>C. albicans</italic> clinical isolates. Populations with high persister (above 6% survival) and low persister (0.0003&#x2013;0.75%) were observed in the two groups of patients (i.e., HIV patients and those under chemotherapy). High-persister isolates were taken exclusively from patients who had been suffering from oral candidiasis for a long time and shared receiving antifungal drugs and long hospital stays. Also, based on statistical analysis, the total information of patients from whom a high persister cell was isolated proved that the persister cell isolate has no connection with <italic>Candida</italic> load of patients at the time of sampling; in other words, it is likely not related to the presence or absence of obvious oral candidiasis symptoms in the patient (<xref ref-type="bibr" rid="B49">Wuyts et al., 2018</xref>). Similar to LaFleur results, our research showed that persister cells were present based on complete removal of isolates using amphotericin B 100 &#x03BC;g/ml, which was not observed in all <italic>C. albicans</italic> isolates (<xref ref-type="bibr" rid="B22">LaFleur et al., 2010</xref>). The reason for this difference in the presence and level of persister cells in some isolates and their absence in others is widely discussed and challenged among microbiological researchers (<xref ref-type="bibr" rid="B7">Bink et al., 2011</xref>; <xref ref-type="bibr" rid="B42">Stewart and Rozen, 2012</xref>). Some researchers have suggested that this difference may be due to the high prevalence of persister, its evolution, and resistance to adverse and stressful conditions (<xref ref-type="bibr" rid="B6">Balaban et al., 2004</xref>; <xref ref-type="bibr" rid="B24">Levin et al., 2014</xref>). According to a study on persister cells of microorganisms, this group of patients is prone to infections, immune system factors, and antibiotics due to low CD4 counts and receiving immunosuppressive drugs, and they are not able to completely eliminate the pathogen. As a result, these factors can cause relapse and recurrence of the disease (<xref ref-type="bibr" rid="B10">Cohen et al., 2013</xref>; <xref ref-type="bibr" rid="B37">Patra and Klumpp, 2013</xref>; <xref ref-type="bibr" rid="B46">Van den Bergh et al., 2017</xref>). It is argued that persister cells are a type of population-based defense tactic counteracting environmental change and stress (<xref ref-type="bibr" rid="B20">Kussell et al., 2005</xref>; <xref ref-type="bibr" rid="B47">Veening et al., 2008</xref>). Our findings showed that there is a high rate of persister in patients undergoing chemotherapy as well as HIV patients, which is consistent with the study by <xref ref-type="bibr" rid="B22">LaFleur et al. (2010)</xref>. The results showed that the expression of BCR1 in the persister group in inducing conditions has an increase of about 10 times compared to the non-persister group. Promoting conditions fully confirmed the results of inducing conditions in that persister isolates have the potential to further increase the expression of <italic>BCR1</italic> and biofilm formation. These data suggested that higher biofilm formation is due to persister cells causing survival against drug treatment in <italic>C. albicans</italic> isolates. Our findings were consistent with the study by <xref ref-type="bibr" rid="B27">Li et al. (2018)</xref> on patients with persister and non-persister candidiasis, and <italic>C. albicans</italic> isolates with persister cells had a higher biofilm intensity. <italic>BCR1</italic> gene is essential for biofilm formation in the laboratory as well as in animal models with catheter-based candidiasis. BCR1 proteins express major surface adhesins such as HWP1 and ALS3,1, and <italic>ALS3,1</italic> genes are BCR1-dependent (<xref ref-type="bibr" rid="B35">Nobile and Mitchell, 2005</xref>; <xref ref-type="bibr" rid="B13">Dwivedi et al., 2011</xref>; <xref ref-type="bibr" rid="B16">Finkel et al., 2012</xref>). These reports and our results show that the surface adhesion step in the biofilm, which is controlled by BCR1 gene, plays a critical role in the production of persister and that the formation of the persister depends on the surface adhesion. The study by <xref ref-type="bibr" rid="B43">Sun et al. (2016)</xref> examined the production of biofilm in different phases and showed that persister are mainly produced in adhesion and biofilm formation phases. In a 2020 study, vaginal candidiasis was detected in a mouse model using <italic>C. albicans</italic> wild-type isolate and <italic>bcr1</italic>&#x0394;&#x0394; mutant, which reported the <italic>BCR1</italic> gene as a recurrence of the disease, and our data are consistent with this study (<xref ref-type="bibr" rid="B48">Wu et al., 2020</xref>).</p>
<p>In our research, the results of <italic>EFG1</italic> expression in the two groups of persister and non-persister showed that there was no significant difference between the two groups in inducing and promoting conditions. <italic>EFG1</italic> regulates morphology (yeast transformation to hyphae) and biofilm development in <italic>C. albicans</italic> (<xref ref-type="bibr" rid="B23">Lassak et al., 2011</xref>). Our results showed that biofilm expansion has no role in the production of persister cells and that persister cell production does not require the formation of a complex biofilm structure. <xref ref-type="bibr" rid="B21">LaFleur et al. (2006)</xref> reported that <italic>efg</italic>&#x0394;<italic>/cph1</italic>&#x0394; mutants were able to produce persister, which is consistent with our results. Therefore, according to the gene expression reports of <italic>EFG1</italic> and <italic>BCR1</italic> biofilm production pathways in this study, it can be concluded that the most important factor in the formation of persister is surface adhesion and biofilm formation, not biofilm development or mature biofilm production. This study suggests that the design of an anti-biofilm drug targeting the <italic>BCR1</italic> can eliminate biofilms and prevent the formation of persister cells in people with mucosal candidiasis or those with candidiasis from venous catheters, dentures, and implants.</p>
<p>The results of <italic>CAT1</italic> in inducing and promoting conditions in two groups of persister and non-persister cells showed that increasing expression of catalase enzyme has a significant role in the production of persister. Our results are consistent with other studies on oxidative stress response pathways on <italic>SOD</italic> and <italic>AHP1</italic>, both of which play a role in the production of persister in <italic>C. albicans</italic> isolates (<xref ref-type="bibr" rid="B7">Bink et al., 2011</xref>; <xref ref-type="bibr" rid="B45">Truong et al., 2016</xref>). The mRNA level of catalase strongly increases against the oxidative stress response in <italic>C. albicans</italic>. Catalase is among the limited antioxidants secreted outside and inside the cell, and in this respect, it acts differently from other antioxidants of oxidative stress response, except for the rapid response and immediate detoxification of H<sub>2</sub>O<sub>2</sub>, and over time, its amount in the cell regulates and reduces the ROS signal. Thus, catalase plays a major role in the rapid regulation of the response to oxidative stress after exposure to H<sub>2</sub>O<sub>2</sub> (<xref ref-type="bibr" rid="B33">Nakagawa, 2008</xref>; <xref ref-type="bibr" rid="B19">Komalapriya et al., 2015</xref>; <xref ref-type="bibr" rid="B39">Pradhan et al., 2017</xref>). These results highlighted the key role of catalase in this pathway, and recent reports and studies highlight the importance of the oxidative stress response and the role of catalase in the production of persister cells. This relationship can be effective and practical for controlling persister formation in fungal biofilms.</p>
<p>Our findings regarding the phylogenetic tree in persister and non-persister cells showed that there is little difference between them and that the affinity between persister and non-persister cells is high. Consequently, it is suggested that the changes in nucleotides may be the root cause of persister cells. Therefore, according to the results of the evolutionary process in other microorganisms as well as our study, persister cells are phenotypic wild-type variants. Presumably, long-term and high-dose treatment with lethal antibiotics can determine the progression of persister cell formation (<xref ref-type="bibr" rid="B32">Mulcahy et al., 2010</xref>; <xref ref-type="bibr" rid="B46">Van den Bergh et al., 2017</xref>).</p>
</sec>
<sec id="S5">
<title>Conclusion</title>
<p>Our findings show that there are small subsets of cells tolerating high doses of fungicidal compounds among <italic>C. albicans</italic> biofilm-forming isolates from chemotherapy and HIV patients, which are called persister cells. The high presence of persister cells in this group of patients may be due to prophylaxis, frequent exposure to antibiotics, and a defective immune system. Molecular analysis of two important genes in the biofilm production pathway showed that biofilm production and binding play an important role in the production of persister cells and that the catalase gene of the oxidative stress response pathway can be mentioned as a therapeutic target for the removal of persister cells. However, the conversion of yeast to hyphae and the maturation of biofilm do not affect the formation of persister.</p>
</sec>
<sec id="S6">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: DDBJ, access number: <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="LC612887">LC612887</ext-link>-<ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="612906">612906</ext-link>.</p>
</sec>
<sec id="S7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the ethical code# IR.AJUMS.REC.1397.894. Written informed consent to participate in this study was provided by the participants&#x2019; legal guardian/next of kin.</p>
</sec>
<sec id="S8">
<title>Author Contributions</title>
<p>MF was involved in the study design and interpretation of the data of the study, and the final editing of the manuscript. EA contributed to all the steps of experimental work, data analysis, and preparation of the manuscript draft. MT contributed to the interpretation and analysis of the data. MH contributed to the collection and preparation of clinical samples. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="pudiscl1">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the grant no. OG-9743 from Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</p>
</fn>
</fn-group>
<ack>
<p>We are thankful to the Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, for cooperation in this study.</p>
</ack>
<sec id="S11" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2021.651221/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2021.651221/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.tiff" id="FS1" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 1</label>
<caption><p>The Mean of 2<sup>&#x2013;&#x0394;ct&#x2013;</sup>of <italic>CAT1, BCR1</italic>, and <italic>EFG1</italic> genes in persister and non-persister isolates in inducing and promoting conditions (<italic>t</italic>-test, &#x002A;<italic>P</italic>-value &#x003C; 0.05, &#x002A;&#x002A;<italic>P</italic>-value &#x003C; 0.01).</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Table_1.docx" id="TS1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Table 1</label>
<caption><p>Demographic information of HIV patients with and without persister cells. <sup>a</sup>The test was performed after pooling the last two groups (Elementary education, Higher education) in order to eliminate small expected frequencies (Fisher&#x2019;s exact test, <italic>P</italic>-value &#x003C; 0.05).</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Table_2.docx" id="TS2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Table 2</label>
<caption><p>Quantitative information about HIV patients in the two groups of persister and non-persister cell. Data are median (IQR) or Mean &#x00B1; SD. <sup>&#x2217;</sup><italic>P</italic>-value &#x003C; 0.05, (<italic>t</italic>-test and Mann&#x2013;Whitney test).</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Table_3.docx" id="TS3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Table 3</label>
<caption><p>Information about patients undergoing chemotherapy in the two groups of persister and non-persister cells. Data are median (IQR) or Mean &#x00B1; SD (<italic>t</italic>-test and Mann&#x2013;Whitney test), <italic>P</italic>-value &#x003C; 0.05.</p></caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aboualigalehdari</surname> <given-names>E.</given-names></name> <name><surname>Birgani</surname> <given-names>M. T.</given-names></name> <name><surname>Fatahinia</surname> <given-names>M.</given-names></name> <name><surname>Hosseinzadeh</surname> <given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Oral colonization by Candida species and associated factors in HIV-infected patients in Ahvaz, southwest Iran.</article-title> <source><italic>Epidemiol. Health</italic></source> <volume>42</volume>:<fpage>e2020033</fpage>. <pub-id pub-id-type="doi">10.4178/epih.e2020033</pub-id> <pub-id pub-id-type="pmid">32512666</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aboualigalehdari</surname> <given-names>E.</given-names></name> <name><surname>Ghafourian</surname> <given-names>S.</given-names></name> <name><surname>Sadeghifard</surname> <given-names>N.</given-names></name> <name><surname>Sekawi</surname> <given-names>Z.</given-names></name></person-group> (<year>2013</year>). <article-title>Is Candida albicans a cause of nosocomial infection in Iran?</article-title> <source><italic>Rev. Med. Microbiol.</italic></source> <volume>24</volume> <fpage>85</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1097/mrm.0b013e3283642433</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname> <given-names>S. B.</given-names></name> <name><surname>Al Marzooq</surname> <given-names>F.</given-names></name> <name><surname>Himratul-Aznita</surname> <given-names>W. H.</given-names></name> <name><surname>Ahmed</surname> <given-names>H. M. A.</given-names></name> <name><surname>Samaranayake</surname> <given-names>L. P.</given-names></name></person-group> (<year>2020</year>). <article-title>Prevalence, virulence and antifungal activity of C. albicans isolated from infected root canals.</article-title> <source><italic>BMC Oral Health</italic></source> <volume>20</volume>:<fpage>347</fpage>. <pub-id pub-id-type="doi">10.1186/s12903-020-01347-5</pub-id> <pub-id pub-id-type="pmid">33256696</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname> <given-names>S.</given-names></name> <name><surname>Khan</surname> <given-names>Z.</given-names></name> <name><surname>Asadzadeh</surname> <given-names>M.</given-names></name> <name><surname>Theyyathel</surname> <given-names>A.</given-names></name> <name><surname>Chandy</surname> <given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis.</article-title> <source><italic>BMC Infect. Dis.</italic></source> <volume>12</volume>:<fpage>230</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-12-230</pub-id> <pub-id pub-id-type="pmid">23009343</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname> <given-names>G. C.</given-names></name> <name><surname>Pavarina</surname> <given-names>A. C.</given-names></name> <name><surname>Sousa</surname> <given-names>T. V.</given-names></name> <name><surname>Klein</surname> <given-names>M. I.</given-names></name></person-group> (<year>2018</year>). <article-title>A quest to find good primers for gene expression analysis of Candida albicans from clinical samples.</article-title> <source><italic>J. Microbiol. Methods</italic></source> <volume>147</volume> <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.mimet.2018.02.010</pub-id> <pub-id pub-id-type="pmid">29454005</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname> <given-names>N. Q.</given-names></name> <name><surname>Merrin</surname> <given-names>J.</given-names></name> <name><surname>Chait</surname> <given-names>R.</given-names></name> <name><surname>Kowalik</surname> <given-names>L.</given-names></name> <name><surname>Leibler</surname> <given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Bacterial persistence as a phenotypic switch.</article-title> <source><italic>Science</italic></source> <volume>305</volume> <fpage>1622</fpage>&#x2013;<lpage>1625</lpage>. <pub-id pub-id-type="doi">10.1126/science.1099390</pub-id> <pub-id pub-id-type="pmid">15308767</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bink</surname> <given-names>A.</given-names></name> <name><surname>Vandenbosch</surname> <given-names>D.</given-names></name> <name><surname>Coenye</surname> <given-names>T.</given-names></name> <name><surname>Nelis</surname> <given-names>H.</given-names></name> <name><surname>Cammue</surname> <given-names>B. P.</given-names></name> <name><surname>Thevissen</surname> <given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>55</volume> <fpage>4033</fpage>&#x2013;<lpage>4037</lpage>. <pub-id pub-id-type="doi">10.1128/aac.00280-11</pub-id> <pub-id pub-id-type="pmid">21746956</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cavalheiro</surname> <given-names>M.</given-names></name> <name><surname>Teixeira</surname> <given-names>M. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Candida biofilms: threats, challenges, and promising strategies.</article-title> <source><italic>Front. Med.</italic></source> <volume>5</volume>:<fpage>28</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2018.00028</pub-id> <pub-id pub-id-type="pmid">29487851</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><collab>Clinical and Laboratory Standards Institute [CLSI]</collab> (<year>2008</year>). <source><italic>Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts.</italic></source> <publisher-loc>Wayne, PA</publisher-loc>: <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>.</citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>N. R.</given-names></name> <name><surname>Lobritz</surname> <given-names>M. A.</given-names></name> <name><surname>Collins</surname> <given-names>J. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Microbial persistence and the road to drug resistance.</article-title> <source><italic>Cell Host Microbe</italic></source> <volume>13</volume> <fpage>632</fpage>&#x2013;<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2013.05.009</pub-id> <pub-id pub-id-type="pmid">23768488</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costa-de-Oliveira</surname> <given-names>S.</given-names></name> <name><surname>Rodrigues</surname> <given-names>A. G.</given-names></name></person-group> (<year>2020</year>). <article-title>Candida albicans antifungal resistance and tolerance in bloodstream infections: the triad yeast-host-antifungal.</article-title> <source><italic>Microorganisms</italic></source> <volume>8</volume>:<fpage>154</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms8020154</pub-id> <pub-id pub-id-type="pmid">31979032</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Brucker</surname> <given-names>K.</given-names></name> <name><surname>De Cremer</surname> <given-names>K.</given-names></name> <name><surname>Cammue</surname> <given-names>B. P.</given-names></name> <name><surname>Thevissen</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Protocol for determination of the persister subpopulation in Candida albicans biofilms.</article-title> <source><italic>Methods Mol. Biol.</italic></source> <volume>1333</volume> <fpage>67</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-2854-5_6</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dwivedi</surname> <given-names>P.</given-names></name> <name><surname>Thompson</surname> <given-names>A.</given-names></name> <name><surname>Xie</surname> <given-names>Z.</given-names></name> <name><surname>Kashleva</surname> <given-names>H.</given-names></name> <name><surname>Ganguly</surname> <given-names>S.</given-names></name> <name><surname>Mitchell</surname> <given-names>A. P.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion.</article-title> <source><italic>PLoS One</italic></source> <volume>6</volume>:<fpage>e16218</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016218</pub-id> <pub-id pub-id-type="pmid">21283544</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Baz</surname> <given-names>A. M.</given-names></name> <name><surname>Mosbah</surname> <given-names>R. A.</given-names></name> <name><surname>Goda</surname> <given-names>R. M.</given-names></name> <name><surname>Mansour</surname> <given-names>B.</given-names></name> <name><surname>Sultana</surname> <given-names>T.</given-names></name> <name><surname>Dahms</surname> <given-names>T. E.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Back to nature: combating candida albicans biofilm, phospholipase and hemolysin using plant essential oils.</article-title> <source><italic>Antibiotics</italic></source> <volume>10</volume>:<fpage>81</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics10010081</pub-id> <pub-id pub-id-type="pmid">33467766</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erk&#x00F6;se</surname> <given-names>G.</given-names></name> <name><surname>Erturan</surname> <given-names>Z.</given-names></name></person-group> (<year>2007</year>). <article-title>Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count.</article-title> <source><italic>Mycoses</italic></source> <volume>50</volume> <fpage>485</fpage>&#x2013;<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1111/j.1439-0507.2007.01393.x</pub-id> <pub-id pub-id-type="pmid">17944711</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname> <given-names>J. S.</given-names></name> <name><surname>Xu</surname> <given-names>W.</given-names></name> <name><surname>Huang</surname> <given-names>D.</given-names></name> <name><surname>Hill</surname> <given-names>E. M.</given-names></name> <name><surname>Desai</surname> <given-names>J. V.</given-names></name> <name><surname>Woolford</surname> <given-names>C. A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Portrait of Candida albicans adherence regulators.</article-title> <source><italic>PLoS Pathog.</italic></source> <volume>8</volume>:<fpage>e1002525</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002525</pub-id> <pub-id pub-id-type="pmid">22359502</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galdiero</surname> <given-names>E.</given-names></name> <name><surname>de Alteriis</surname> <given-names>E.</given-names></name> <name><surname>De Natale</surname> <given-names>A.</given-names></name> <name><surname>D&#x2019;Alterio</surname> <given-names>A.</given-names></name> <name><surname>Siciliano</surname> <given-names>A.</given-names></name> <name><surname>Guida</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>10</volume>:<fpage>5780</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-62746-w</pub-id> <pub-id pub-id-type="pmid">32238858</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jayachandran</surname> <given-names>A. L.</given-names></name> <name><surname>Katragadda</surname> <given-names>R.</given-names></name> <name><surname>Thyagarajan</surname> <given-names>R.</given-names></name> <name><surname>Vajravelu</surname> <given-names>L.</given-names></name> <name><surname>Manikesi</surname> <given-names>S.</given-names></name> <name><surname>Kaliappan</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Oral Candidiasis among cancer patients attending a tertiary Care Hospital in Chennai, South India: an evaluation of Clinicomycological association and antifungal susceptibility pattern.</article-title> <source><italic>Can. J. Infect. Dis. Med. Microbiol.</italic></source> <volume>2016</volume>:<fpage>8758461</fpage>.</citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Komalapriya</surname> <given-names>C.</given-names></name> <name><surname>Kaloriti</surname> <given-names>D.</given-names></name> <name><surname>Tillmann</surname> <given-names>A. T.</given-names></name> <name><surname>Yin</surname> <given-names>Z.</given-names></name> <name><surname>Herrero-de-Dios</surname> <given-names>C.</given-names></name> <name><surname>Jacobsen</surname> <given-names>M. D.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Integrative model of oxidative stress adaptation in the fungal pathogen Candida albicans.</article-title> <source><italic>PLoS One</italic></source> <volume>10</volume>:<fpage>e0137750</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0137750</pub-id> <pub-id pub-id-type="pmid">26368573</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kussell</surname> <given-names>E.</given-names></name> <name><surname>Kishony</surname> <given-names>R.</given-names></name> <name><surname>Balaban</surname> <given-names>N. Q.</given-names></name> <name><surname>Leibler</surname> <given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Bacterial persistence: a model of survival in changing environments.</article-title> <source><italic>Genetics</italic></source> <volume>169</volume> <fpage>1807</fpage>&#x2013;<lpage>1814</lpage>.</citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaFleur</surname> <given-names>M. D.</given-names></name> <name><surname>Kumamoto</surname> <given-names>C. A.</given-names></name> <name><surname>Lewis</surname> <given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>Candida albicans biofilms produce antifungal-tolerant persister cells.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>50</volume> <fpage>3839</fpage>&#x2013;<lpage>3846</lpage>. <pub-id pub-id-type="doi">10.1128/aac.00684-06</pub-id> <pub-id pub-id-type="pmid">16923951</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LaFleur</surname> <given-names>M. D.</given-names></name> <name><surname>Qi</surname> <given-names>Q.</given-names></name> <name><surname>Lewis</surname> <given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Patients with long-term oral carriage harbor high-persister mutants of Candida albicans.</article-title> <source><italic>Antimicrob. Agents chemother.</italic></source> <volume>54</volume> <fpage>39</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1128/aac.00860-09</pub-id> <pub-id pub-id-type="pmid">19841146</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lassak</surname> <given-names>T.</given-names></name> <name><surname>Schneider</surname> <given-names>E.</given-names></name> <name><surname>Bussmann</surname> <given-names>M.</given-names></name> <name><surname>Kurtz</surname> <given-names>D.</given-names></name> <name><surname>Manak</surname> <given-names>J. R.</given-names></name> <name><surname>Srikantha</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Target specificity of the Candida albicans Efg1 regulator.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>82</volume> <fpage>602</fpage>&#x2013;<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07837.x</pub-id> <pub-id pub-id-type="pmid">21923768</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname> <given-names>B. R.</given-names></name> <name><surname>Concepci&#x00F3;n-Acevedo</surname> <given-names>J.</given-names></name> <name><surname>Udekwu</surname> <given-names>K. I.</given-names></name></person-group> (<year>2014</year>). <article-title>Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics.</article-title> <source><italic>Curr. Opin. Microbiol.</italic></source> <volume>21</volume> <fpage>18</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2014.06.016</pub-id> <pub-id pub-id-type="pmid">25090240</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>K.</given-names></name></person-group> (<year>2005</year>). <article-title>Persister cells and the riddle of biofilm survival.</article-title> <source><italic>Biochemistry</italic></source> <volume>70</volume> <fpage>267</fpage>&#x2013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1007/s10541-005-0111-6</pub-id> <pub-id pub-id-type="pmid">15807669</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>P.</given-names></name> <name><surname>Seneviratne</surname> <given-names>C. J.</given-names></name> <name><surname>Alpi</surname> <given-names>E.</given-names></name> <name><surname>Vizcaino</surname> <given-names>J. A.</given-names></name> <name><surname>Jin</surname> <given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Delicate metabolic control and coordinated stress response critically determine antifungal tolerance of Candida albicans biofilm persisters.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>59</volume> <fpage>6101</fpage>&#x2013;<lpage>6112</lpage>. <pub-id pub-id-type="doi">10.1128/aac.00543-15</pub-id> <pub-id pub-id-type="pmid">26195524</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>W.-S.</given-names></name> <name><surname>Chen</surname> <given-names>Y.-C.</given-names></name> <name><surname>Kuo</surname> <given-names>S.-F.</given-names></name> <name><surname>Chen</surname> <given-names>F.-J.</given-names></name> <name><surname>Lee</surname> <given-names>C.-H.</given-names></name></person-group> (<year>2018</year>). <article-title>The impact of biofilm formation on the persistence of candidemia.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>9</volume>:<fpage>1196</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.01196</pub-id> <pub-id pub-id-type="pmid">29915571</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maheronnaghsh</surname> <given-names>M.</given-names></name> <name><surname>Fatahinia</surname> <given-names>M.</given-names></name> <name><surname>Dehghan</surname> <given-names>P.</given-names></name> <name><surname>Teimoori</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Identification of Candida species and antifungal susceptibility in cancer patients with oral lesions in ahvaz, Southern West of Iran.</article-title> <source><italic>Adv. Biomed. Res.</italic></source> <volume>9</volume>:<fpage>50</fpage>. <pub-id pub-id-type="doi">10.4103/abr.abr_214_19</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merseguel</surname> <given-names>K. B.</given-names></name> <name><surname>Nishikaku</surname> <given-names>A. S.</given-names></name> <name><surname>Rodrigues</surname> <given-names>A. M.</given-names></name> <name><surname>Padovan</surname> <given-names>A. C.</given-names></name> <name><surname>Ferreira</surname> <given-names>R. C.</given-names></name> <name><surname>de Azevedo Melo</surname> <given-names>A. S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Genetic diversity of medically important and emerging Candida species causing invasive infection.</article-title> <source><italic>BMC Infect. Dis.</italic></source> <volume>15</volume>:<fpage>57</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-015-0793-3</pub-id> <pub-id pub-id-type="pmid">25887032</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mirhendi</surname> <given-names>H.</given-names></name> <name><surname>Makimura</surname> <given-names>K.</given-names></name> <name><surname>Khoramizadeh</surname> <given-names>M.</given-names></name> <name><surname>Yamaguchi</surname> <given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>A one-enzyme PCR-RFLP assay for identification of six medically important Candida species.</article-title> <source><italic>Nihon Ishinkin Gakkai Zasshi</italic></source> <volume>47</volume> <fpage>225</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.3314/jjmm.47.225</pub-id> <pub-id pub-id-type="pmid">16940958</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moazeni</surname> <given-names>M.</given-names></name> <name><surname>Khoramizadeh</surname> <given-names>M. R.</given-names></name> <name><surname>Teimoori-Toolabi</surname> <given-names>L.</given-names></name> <name><surname>Noorbakhsh</surname> <given-names>F.</given-names></name> <name><surname>Rezaie</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>The effect of EFG1 gene silencing on down-regulation of SAP5 gene, by use of RNAi technology.</article-title> <source><italic>Acta Med. Iran.</italic></source> <volume>52</volume> <fpage>9</fpage>&#x2013;<lpage>14</lpage>.</citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulcahy</surname> <given-names>L. R.</given-names></name> <name><surname>Burns</surname> <given-names>J. L.</given-names></name> <name><surname>Lory</surname> <given-names>S.</given-names></name> <name><surname>Lewis</surname> <given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Emergence of <italic>Pseudomonas aeruginosa</italic> strains producing high levels of persister cells in patients with cystic fibrosis.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>192</volume> <fpage>6191</fpage>&#x2013;<lpage>6199</lpage>. <pub-id pub-id-type="doi">10.1128/jb.01651-09</pub-id> <pub-id pub-id-type="pmid">20935098</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname> <given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells.</article-title> <source><italic>Microbiol. Immunol.</italic></source> <volume>52</volume> <fpage>16</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1111/j.1348-0421.2008.00006.x</pub-id> <pub-id pub-id-type="pmid">18352908</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nikoomanesh</surname> <given-names>F.</given-names></name> <name><surname>Roudbarmohammadi</surname> <given-names>S.</given-names></name> <name><surname>Roudbary</surname> <given-names>M.</given-names></name> <name><surname>Bayat</surname> <given-names>M.</given-names></name> <name><surname>Heidari</surname> <given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Investigation of bcr1 gene expression in Candida albicans isolates by RTPCR technique and its impact on biofilm formation.</article-title> <source><italic>Infect. Epidemiol. Microbiol.</italic></source> <volume>2</volume> <fpage>22</fpage>&#x2013;<lpage>24</lpage>.</citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nobile</surname> <given-names>C. J.</given-names></name> <name><surname>Mitchell</surname> <given-names>A. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p.</article-title> <source><italic>Curr. Biol.</italic></source> <volume>15</volume> <fpage>1150</fpage>&#x2013;<lpage>1155</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2005.05.047</pub-id> <pub-id pub-id-type="pmid">15964282</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname> <given-names>S.</given-names></name> <name><surname>Majumdar</surname> <given-names>B.</given-names></name> <name><surname>Sarode</surname> <given-names>S. C.</given-names></name> <name><surname>Sarode</surname> <given-names>G. S.</given-names></name> <name><surname>Awan</surname> <given-names>K. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Oropharyngeal candidosis in HIV-infected patients&#x2014;an update.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>9</volume>:<fpage>980</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.00980</pub-id> <pub-id pub-id-type="pmid">29867882</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patra</surname> <given-names>P.</given-names></name> <name><surname>Klumpp</surname> <given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Population dynamics of bacterial persistence.</article-title> <source><italic>PLoS One</italic></source> <volume>8</volume>:<fpage>e62814</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0062814</pub-id> <pub-id pub-id-type="pmid">23675428</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piekarska</surname> <given-names>K.</given-names></name> <name><surname>Hardy</surname> <given-names>G.</given-names></name> <name><surname>Mol</surname> <given-names>E.</given-names></name> <name><surname>van den Burg</surname> <given-names>J.</given-names></name> <name><surname>Strijbis</surname> <given-names>K.</given-names></name> <name><surname>van Roermund</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>The activity of the glyoxylate cycle in peroxisomes of Candida albicans depends on a functional &#x03B2;-oxidation pathway: evidence for reduced metabolite transport across the peroxisomal membrane.</article-title> <source><italic>Microbiology</italic></source> <volume>154</volume> <fpage>3061</fpage>&#x2013;<lpage>3072</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.2008/020289-0</pub-id> <pub-id pub-id-type="pmid">18832312</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pradhan</surname> <given-names>A.</given-names></name> <name><surname>Herrero-de-Dios</surname> <given-names>C.</given-names></name> <name><surname>Belmonte</surname> <given-names>R.</given-names></name> <name><surname>Budge</surname> <given-names>S.</given-names></name> <name><surname>Garcia</surname> <given-names>A. L.</given-names></name> <name><surname>Kolmogorova</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Elevated catalase expression in a fungal pathogen is a double-edged sword of iron.</article-title> <source><italic>PLoS Pathog.</italic></source> <volume>13</volume>:<fpage>e1006405</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006405</pub-id> <pub-id pub-id-type="pmid">28542620</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Putranti</surname> <given-names>A.</given-names></name> <name><surname>Asmarawati</surname> <given-names>T.</given-names></name> <name><surname>Rachman</surname> <given-names>B.</given-names></name> <name><surname>Hadi</surname> <given-names>U.</given-names></name></person-group> (<year>2018</year>). <article-title>Oral candidiasis as clinical manifestation of HIV/AIDS infection in Airlangga University hospital patients.</article-title> <source><italic>IOP Conf. Ser. Earth Environ. Sci.</italic></source> <volume>125</volume>:<fpage>012063</fpage>. <pub-id pub-id-type="doi">10.1088/1755-1315/125/1/012063</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname> <given-names>G.</given-names></name> <name><surname>Bernardi</surname> <given-names>T. L.</given-names></name> <name><surname>Schaker</surname> <given-names>P. D. C.</given-names></name> <name><surname>Menegotto</surname> <given-names>M.</given-names></name> <name><surname>Valente</surname> <given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Rapid yeast DNA extraction by boiling and freeze-thawing without using chemical reagents and DNA purification.</article-title> <source><italic>Braz. Arch. Biol. Technol.</italic></source> <volume>55</volume> <fpage>319</fpage>&#x2013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1590/s1516-89132012000200020</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>B.</given-names></name> <name><surname>Rozen</surname> <given-names>D. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Genetic variation for antibiotic persistence in <italic>Escherichia coli</italic>.</article-title> <source><italic>Evolution</italic></source> <volume>66</volume> <fpage>933</fpage>&#x2013;<lpage>939</lpage>. <pub-id pub-id-type="doi">10.1111/j.1558-5646.2011.01467.x</pub-id> <pub-id pub-id-type="pmid">22380453</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Chu</surname> <given-names>H.</given-names></name> <name><surname>Guo</surname> <given-names>J.</given-names></name> <name><surname>Jiang</surname> <given-names>G.</given-names></name> <name><surname>Qi</surname> <given-names>Q.</given-names></name></person-group> (<year>2016</year>). <article-title>Candida albicans amphotericin B-tolerant persister formation is closely related to surface adhesion.</article-title> <source><italic>Mycopathologia</italic></source> <volume>181</volume> <fpage>41</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1007/s11046-015-9894-1</pub-id> <pub-id pub-id-type="pmid">26381156</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taff</surname> <given-names>H. T.</given-names></name> <name><surname>Mitchell</surname> <given-names>K. F.</given-names></name> <name><surname>Edward</surname> <given-names>J. A.</given-names></name> <name><surname>Andes</surname> <given-names>D. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Mechanisms of Candida biofilm drug resistance.</article-title> <source><italic>Future Microbiol.</italic></source> <volume>8</volume> <fpage>1325</fpage>&#x2013;<lpage>1337</lpage>.</citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname> <given-names>T.</given-names></name> <name><surname>Zeng</surname> <given-names>G.</given-names></name> <name><surname>Qingsong</surname> <given-names>L.</given-names></name> <name><surname>Kwang</surname> <given-names>L. T.</given-names></name> <name><surname>Tong</surname> <given-names>C.</given-names></name> <name><surname>Chan</surname> <given-names>F. Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Comparative ploidy proteomics of Candida albicans biofilms unraveled the role of the AHP1 gene in the biofilm persistence against amphotericin B.</article-title> <source><italic>Mol. Cell. Proteom.</italic></source> <volume>15</volume> <fpage>3488</fpage>&#x2013;<lpage>3500</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.m116.061523</pub-id> <pub-id pub-id-type="pmid">27644984</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van den Bergh</surname> <given-names>B.</given-names></name> <name><surname>Fauvart</surname> <given-names>M.</given-names></name> <name><surname>Michiels</surname> <given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Formation, physiology, ecology, evolution and clinical importance of bacterial persisters.</article-title> <source><italic>FEMS Microbiol. Rev.</italic></source> <volume>41</volume> <fpage>219</fpage>&#x2013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1093/femsre/fux001</pub-id> <pub-id pub-id-type="pmid">28333307</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Veening</surname> <given-names>J.-W.</given-names></name> <name><surname>Smits</surname> <given-names>W. K.</given-names></name> <name><surname>Kuipers</surname> <given-names>O. P.</given-names></name></person-group> (<year>2008</year>). <article-title>Bistability, epigenetics, and bet-hedging in bacteria.</article-title> <source><italic>Annu. Rev. Microbiol.</italic></source> <volume>62</volume> <fpage>193</fpage>&#x2013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.62.081307.163002</pub-id> <pub-id pub-id-type="pmid">18537474</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Shen</surname> <given-names>L.</given-names></name> <name><surname>Dong</surname> <given-names>C.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Biofilm formation of Candida albicans facilitates fungal infiltration and persister cell formation in vaginal candidiasis.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>11</volume>:<fpage>1117</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.01117</pub-id> <pub-id pub-id-type="pmid">32582081</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wuyts</surname> <given-names>J.</given-names></name> <name><surname>Van Dijck</surname> <given-names>P.</given-names></name> <name><surname>Holtappels</surname> <given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Fungal persister cells: the basis for recalcitrant infections?</article-title> <source><italic>PLoS Pathog.</italic></source> <volume>14</volume>:<fpage>e1007301</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1007301</pub-id> <pub-id pub-id-type="pmid">30335865</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname> <given-names>Y.</given-names></name> <name><surname>Makimura</surname> <given-names>K.</given-names></name> <name><surname>Merhendi</surname> <given-names>H.</given-names></name> <name><surname>Ueda</surname> <given-names>K.</given-names></name> <name><surname>Nishiyama</surname> <given-names>Y.</given-names></name> <name><surname>Yamaguchi</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Comparison of different methods for extraction of mitochondrial DNA from human pathogenic yeasts.</article-title> <source><italic>Jpn. J. infect. Dis.</italic></source> <volume>55</volume>:<fpage>122</fpage>.</citation></ref>
</ref-list>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/goldman-srv/webprank/">https://www.ebi.ac.uk/goldman-srv/webprank/</ext-link></p></fn>
</fn-group>
</back>
</article>